Results 141 to 150 of about 61,613 (221)

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient

, 2010
J Verwimp1, F Geurs1, S Ponette2, J Ponette2, J Martens3, K Bulté21Department of Medical Oncology, 2Department of Gastroenterology, 3Department of Nephrology, Regionaal Ziekenhuis Sint-Maria, Ziekenhuislaan, Halle, BelgiumAbstract: We present ...
et al, F Geurs, S Ponette, J Verwimp
core  

Comparing the efficacy and safety of raltitrexed combined with irinotecan administered in different dose-schedule patterns for the second-line treatment of metastatic colorectal cancer: an exploratory, observational post hoc analysis from the prospective SALLY registry cohort. [PDF]

J Gastrointest Oncol
Yu N, Tong Z, Fan Y, Wang Z, Wang J, Yuan Y, Weng S.   +6 more
europepmc   +1 more source

Agarose-Encapsulated Multifunctional Microspheres with High Drug Payload and Multimodal Imaging Capability for Arterial Embolization-Associated Hyperthermia Therapy. [PDF]

Molecules
Zhang Y, Huang S, Kou Q, Xu Y, Xu Y, Chen L, Wang X, Shi C.   +7 more
europepmc   +1 more source

Trastuzumab rezetecan (SHR-A1811) for the treatment of HER2-positive advanced colorectal cancer: a report of two cases. [PDF]

J Gastrointest Oncol
Chen D, Zheng Y.
europepmc   +1 more source

Lurbinectedin plus irinotecan in pretreated gastroenteropancreatic neuroendocrine neoplasms: results of a phase II expansion cohort. [PDF]

ESMO Open
Garcia-Carbonero R, Cote GM, Le Cesne A, Antón-Pascual B, Alonso-Gordoa T, Falcon A, Gil-Torralvo A, Martínez S, Kahatt C, Alfaro V, Zubiaur P, Jimenez J, Siguero M, Molina-Cerrillo J.   +13 more
europepmc   +1 more source

Targeting FAR1 to inhibit intestinal macrophage ferroptosis: repurposing irinotecan as a novel sepsis therapy. [PDF]

Apoptosis
Deng H, Wang W, Li Q, Xiang X, Zhu Y, Zhang Z, Zhou X, Wu Y, Zhang J, Liu L, Li T.   +10 more
europepmc   +1 more source

Survival Outcomes in Metastatic Colorectal Cancer Patients with BRAF Mutations Undergoing Targeted Chemotherapy: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Controlled Trials. [PDF]

J Gastrointest Cancer
Kazmi SK, Rehman MA, Tariq H, Kabir A, Ahmed J, Yee NSS.   +5 more
europepmc   +1 more source

Irinotecan induces intestinal atrophy and compromises duodenal motility and mucosal permeability: in vivo and in vitro evaluations. [PDF]

Cancer Chemother Pharmacol
Arendt N, Payo-Serafín T, Lennernäs H, Heindryckx F, Sjöblom M.   +4 more
europepmc   +1 more source

Therapeutic Effects of Ceranib-2 and Irinotecan Combination on Colon Cancer. [PDF]

Curr Issues Mol Biol
Selvi O, Vejselova Sezer C, İzgördü H, Kutlu HM.   +3 more
europepmc   +1 more source

Acquired Chemoresistance in Colorectal Cancer: Therapy-Induced Signalling Adaptation, Cellular Plasticity and Mechanism-Guided Therapeutic Strategies. [PDF]

Cells
Bartusik-Aebisher D, Wilk I, George BP, Aebisher D.   +3 more
europepmc   +1 more source